Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
University of Utah
Celldex Therapeutics
Fox Chase Cancer Center
University of Texas Southwestern Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Iowa
Icahn School of Medicine at Mount Sinai
Roswell Park Cancer Institute
University of Michigan Rogel Cancer Center